RIGL Operating Cash Flow (Statement)

Rigel Pharmaceuticals Inc · Operating Cash Flow (Statement)

RIGL logo

RIGL Operating Cash Flow (Statement)

Latest reported$79.39M
RIGL TTM Cash from Operations (-$15.98M → $79.39M)
High-resolution chart · PNG

RIGL operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
79,389,000
79,273,000
75,655,000
68,178,000
65,826,000
35,591,000
31,471,000
10,728,000
-12,310,000
-6,682,000
-5,743,000
-21,412,000
-33,354,000
-52,195,000
-73,758,000
-70,935,000
-67,931,000
196,000
5,878,000
9,392,000
207,000
-69,047,000
-52,185,000
-46,262,000
-41,421,000
-44,034,000
-41,510,000
-20,217,000
-25,658,000
-36,001,000
-58,826,000
-90,185,000
-87,713,000
-80,189,000
-77,557,000
-70,306,000
-75,267,000
-74,231,000
-75,889,000
-77,222,000
-64,108,000
-63,820,000
-23,413,000
-24,666,000
-33,540,000
-35,338,000
-69,753,000
-73,589,000
-76,001,000
-77,378,000
-86,061,000
-88,729,000
-87,611,000
-87,030,000
-85,192,000
-82,292,000
-75,460,000
-71,885,000
-69,375,000
-40,453,000
-46,668,000
49,072,000
46,743,000
13,201,000
6,823,000
-96,809,000
-102,779,000
-106,645,000
-105,787,000
-105,500,000
-103,518,000
-84,753,000
-73,803,000
-63,850,000
-52,207,000
-54,719,000
-49,309,000
-41,128,000
-35,836,000
-29,444,000
-35,045,000
-39,221,000
-35,170,000
-35,951,000
-33,603,000
-33,666,000
-38,152,000
-42,725,000
-40,972,000
-38,760,000
-32,440,000
-37,183,000
-31,812,000
-33,836,000
-34,528,000
-22,912,000
-21,307,000
-16,020,000
-15,981,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.